An Open_label, Randomized Controlled Trial of Pramipexole versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD with Mild Neurocognitive Disorder (MND) in Persons with HIV
Primary Objective
To compare pramipexole to escitalopram in the treatment of major depressive disorder in people living with HIV.
Description
The purpose of this research study is to evaluate the safety and efficacy of pramipexole extended release (ER) versus escitalopram for the treatment of major depressive disorder (MDD) and mild neurocognitive disorder (MND) in people living with HIV (PWH).
Details
Age
Adult
Eligibility
Individuals living with HIV and with a diagnosis of major depressive disorder
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Thomas Campbell
Study ID
Protocol Number: 24-2084
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers